β Cell function after Roux-en-Y gastric bypass surgery or reduced energy intake alone in people with obesity
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
β Cell function after Roux-en-Y gastric bypass surgery or reduced energy intake alone in people with obesity. / Mittendorfer, Bettina; Patterson, Bruce W; Magkos, Faidon; Yoshino, Mihoko; Bradley, David P; Eagon, J Christopher; Klein, Samuel.
In: JCI insight, Vol. 8, No. 12, e170307, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - β Cell function after Roux-en-Y gastric bypass surgery or reduced energy intake alone in people with obesity
AU - Mittendorfer, Bettina
AU - Patterson, Bruce W
AU - Magkos, Faidon
AU - Yoshino, Mihoko
AU - Bradley, David P
AU - Eagon, J Christopher
AU - Klein, Samuel
N1 - Funding: This study was supported by NIH grants R01 DK037948, R01 DK101578, P30 DK056341 (Washington University Nutrition and Obesity Research Center), P30 DK020579 (Washington University Diabetes Research Center), and UL1 TR002345 (Washington University Institute of Clinical and Translational Sciences), and grants from the American Diabetes Association (1-18-ICTS-119), the Longer Life Foundation (2019-011).
PY - 2023
Y1 - 2023
N2 - Background/Aims: The effects of diet-induced weight loss (WL) and WL after Roux-en-Y gastric bypass (RYGB) surgery on β cell function (BCF) are unclear because of conflicting results from different studies, presumably because of differences in the methods used to measure BCF, the amount of WL between treatment groups, and baseline BCF. We evaluated the effect of WL after RYGB surgery or reduced energy intake alone on BCFβ-cell function in people with obesity with and without type 2 diabetes.Methods: BCF (insulin secretion in relationship to plasma glucose) was assessed before and after glucose or mixed-meal ingestion before and after (a) progressive amounts (6%, 11%, 16%) of WL induced by a low-calorie diet (LCD) in people with obesity without diabetes, (b) ~20% WL after RYGB surgery or laparoscopic adjustable gastric banding (LAGB) in people with obesity without diabetes, and (c) ~20% WL after RYGB surgery or LCD alone in people with obesity and diabetes.Results: Diet-induced progressive WL in people without diabetes progressively decreased BCF. Marked WL after LAGB or RYGB in people without diabetes did not alter BCF. Marked WL after LCD or RYGB in people with diabetes markedly increased BCF, without a difference between the two groups.Conclusion: Marked WL increases BCF in people with obesity and diabetes but not in people with obesity without diabetes. The effect of RYGB-induced WL on BCF is not different from the effect of matched WL after LAGB or LCD alone.Clinical trial registration numbers: NCT00981500, NCT02207777, NCT01299519
AB - Background/Aims: The effects of diet-induced weight loss (WL) and WL after Roux-en-Y gastric bypass (RYGB) surgery on β cell function (BCF) are unclear because of conflicting results from different studies, presumably because of differences in the methods used to measure BCF, the amount of WL between treatment groups, and baseline BCF. We evaluated the effect of WL after RYGB surgery or reduced energy intake alone on BCFβ-cell function in people with obesity with and without type 2 diabetes.Methods: BCF (insulin secretion in relationship to plasma glucose) was assessed before and after glucose or mixed-meal ingestion before and after (a) progressive amounts (6%, 11%, 16%) of WL induced by a low-calorie diet (LCD) in people with obesity without diabetes, (b) ~20% WL after RYGB surgery or laparoscopic adjustable gastric banding (LAGB) in people with obesity without diabetes, and (c) ~20% WL after RYGB surgery or LCD alone in people with obesity and diabetes.Results: Diet-induced progressive WL in people without diabetes progressively decreased BCF. Marked WL after LAGB or RYGB in people without diabetes did not alter BCF. Marked WL after LCD or RYGB in people with diabetes markedly increased BCF, without a difference between the two groups.Conclusion: Marked WL increases BCF in people with obesity and diabetes but not in people with obesity without diabetes. The effect of RYGB-induced WL on BCF is not different from the effect of matched WL after LAGB or LCD alone.Clinical trial registration numbers: NCT00981500, NCT02207777, NCT01299519
U2 - 10.1172/jci.insight.170307
DO - 10.1172/jci.insight.170307
M3 - Journal article
C2 - 37166995
VL - 8
JO - JCI Insight
JF - JCI Insight
SN - 2379-3708
IS - 12
M1 - e170307
ER -
ID: 346246928